US, Moderna in Dispute Over Vaccine Patent Rights - Reports

WASHINGTON (Sputnik) - The US government and Moderna pharmaceutical company are embroiled in a bitter dispute over the patent rights for the central component of Moderna’s COVID-19 vaccine, The New York Times reported citing officials familiar with the matter.